Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
Clinical trial NCT00232596 · COMPLETED
Trial details
- NCT number
- NCT00232596
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-01-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.